As financial institutions worldwide grapple with how to turn climate-related risks into credible stress testing scenarios, new guidance on climate stress testing for banks offers a timely roadmap.

SAS Viya helps accelerate credit approvals, boost performance and enhance the customer experience CARY, N.C., Dec. 8, 2025 /PRNewswire/ -- To modernize its lending operations in Romania, Nexent Bank ...

As co-chair of the Security & Governance Workstream, SAS contributes a robust background in AI governance, risk management, and security, along with a demonstrated history of real-world success. SAS ...

Google's AI board now includes Nano Banana Pro​ to create presentations from your photos and documents - and it's free. Try it and see what you think.

Hoffmann-La Roche Limited (Roche Canada) is proud to announce that Health Canada has granted market authorization for TNKase® ...

By focusing automation efforts on high-volume, low-variability tasks rather than attempting to automate judgment, companies ...

Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Executive Officer, Andrew Toy, will present at the J.P. Morgan 2026 ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Vivek Yadav, an engineering manager from ...

HealthLeaders' inaugural Chief Digital Executive Exchange (CDEX) opened Thursday with a strong discussion around financial value and responsibility.

Resolve Sleep Health, the leading provider of integrated sleep health solutions, is proud to announce the strategic acquisition of Sleep Therapeutics; a prominent 25-clinic group operating in Alberta, ...

The Feast of the Presentation of the Blessed Virgin Mary, celebrated annually on November 21st, commemorates the presentation of the Blessed Virgin as a child by her parents in the Temple in Jerusalem ...

The Derisq AI Report uses GATC Health’s proprietary AI platform to provide biopharma leaders and investors with an objective, data-driven assessment of a drug candidate’s likely endpoint ...